Navigation Links
ERT Reports Fourth Quarter and Full Year 2010 Operating Results on March 1, 2011
Date:2/9/2011

PHILADELPHIA, Feb. 9, 2011 /PRNewswire/ -- ERT (Nasdaq: ERES) announced today that it will release its operating results for fourth quarter and full year 2010 Tuesday, March 1, after the market closes. After the release, the Company will host a conference call at 5:00 PM ET that day.

For the conference call, interested participants should dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when calling internationally. There will be a playback available as well. To listen to the playback, please call 1-877-344-7529 when calling within the United States or 1-412-317-0088 when calling internationally.  Conference code for playback is 448386.

This call is being webcast by MultiVu and can be accessed at ERT's website at www.ert.com. The webcast may also be accessed via the direct link at http://www.videonewswire.com/event.asp?id=76717.   The webcast can be accessed for up to one year on either site.  

ERT (www.ert.com) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.  It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic Patient Reported Outcomes (ePRO) in multiple modalities across all phases of clinical research.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.Media Contact:Keith Schneck, CFOTel: 215-972-0420kschneck@ert.com
'/>"/>

SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
2. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
3. Par Pharmaceutical Reports Second Quarter 2008 Results
4. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
5. Pharmos Corporation Reports 2008 Second Quarter Results
6. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
7. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
8. BMP Sunstone Reports Second Quarter 2008 Financial Results
9. ULURU Inc. Reports Second Quarter 2008 Financial Results
10. Immtech Reports Fiscal First Quarter 2009 Results
11. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Dec. 7, 2016  Muse bio, a privately-held company ... announced that Dr. Kevin Ness has been ... of Directors. Kevin succeeds Muse bio,s ... company,s Chief Science Officer as well as remains Slade ... the BioDesign Center at the RAS Energy Institute at ...
(Date:12/7/2016)... ... December 07, 2016 , ... Cambrian Innovation , ... facilities, today announced that one of the nation’s fastest growing craft breweries, ... purchase agreement (WEPA). Under the WEPA, a first for the industrial wastewater treatment ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... access program for SmartBiome -- a novel metagenomic deep-sequencing research platform. SmartBiome ... and detection of hundreds of different genes. The selective early access program ...
(Date:12/6/2016)... Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: SQIDF), today reported its ... ended September 30, 2016. ... , SQI is a ... develops and commercializes proprietary technologies and products for advanced multiplexed diagnostics. ... $1.4 million more than tripling prior years revenue. ...
Breaking Biology Technology:
(Date:11/30/2016)... 30, 2016 Not many of us realize that we spend ? of ... we need to do it well. Inadequate sleep levels have been found to lead ... diabetes, and even cancer. Maybe now is the best time to rethink ... them to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... France , November 29, 2016 Nearly one ... Continue Reading ... ... is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: ...
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
Breaking Biology News(10 mins):